Mina Pastagia

Company: Armata Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Armata Clinical Trials Overview of Bacteriophage Administration for Difficult-to-Treat Infections 12:00 pm

Value of a phage cocktail approach in subjects with chronic pseudomonal respiratory infections Similarities of phage distribution and phage kinetics between cystic fibrosis and non-cystic fibrosis bronchiectasis subjects administered nebulized phage (AP-PA02) Purity of high dose S. aureus phage (AP-SA02) and ability to safely dose escalate intravenously over multiple days in subjects with S. aureus…Read more

day: Day One